Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Amyris

Rhode, Rare, R.E.M: The celebrity beauty brands that have thrived (and ones that didn't)

Not everyone can build a Fenty Beauty-style empire, or become the mastermind behind a Rhode lip gloss phone case. What about the ones who got left behind? asks Maddy Mussen

Evening Standard

In synthetic biology, startups and incumbent companies should be partners, not foes

In synthetic biology, startups and incumbent companies should be partners, not foes

In this crucial area of innovation, established companies and startups must work together to deliver the benefits that the science promises.

Benzinga's Top Ratings Upgrades, Downgrades For November 10, 2022

Benzinga's Top Ratings Upgrades, Downgrades For November 10, 2022

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Benzinga's Top Ratings Upgrades, Downgrades For November 9, 2022

Benzinga's Top Ratings Upgrades, Downgrades For August 10, 2022

Benzinga's Top Ratings Upgrades, Downgrades For June 24, 2022

Benzinga's Top Ratings Upgrades, Downgrades For May 25, 2022

Upgrades Credit Suisse upgraded the previous rating for Molecular Partners AG (NASDAQ:MOLN) from Underperform to Neutral. NoneAt the moment, the stock has a 52-week-high of $32.04 and a 52-week-low of $5.92. Molecular Partners closed at $6.88 at the end of the last trading period.

inkl

Read news from The Economist, FT, and more,
with one subscription

Is Amyris a Buy Under $5?

Is Amyris a Buy Under $5?

Clean health and beauty company Amyris (AMRS) is working with an immunotherapy company to accelerate the commercialization of a next-generation COVID-19 vaccine, which is expected to boost the company’s near-term prospects if approved. However, the stock has suffered a double-digit percentage price decline this year, closing the last session at…

People

Khloe Kardashian

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

Activision Blizzard

Palo Alto Networks

Micron Technology

inkl

Read news from The Economist, FT, and more,
with one subscription

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play